Also trades as: ABT.TO (TSX) · $vol 0M · ABL.DE (XETRA) · $vol 0M · ABT.SW (SIX) · $vol 0M

$103.10

-1.78 (-1.70%)

Weekly Expected Move ±3.5%

$96 $100 $104 $107 $111

NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 72 · $178.4B mcap · 1.72B float · 0.610% daily turnover · Short 48% of daily vol

Credit Risk of going bust: lower than 80% of companies Debt: 15.5% of company value Bonds: $1.35B held by 411 funds, 57 bp over Treasuries → details ▾

Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.24 (down 99%), Abbott Laboratories would be worth roughly what it owes.
Total debt $32.61B against a stock market value of $178.40B.
Distance to default 9.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.81B (short-term plus half of long-term), stock volatility 27.5%; Altman Z 3.24. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

54.9 / 100

NoneWeakNarrowWide

Primary source: Efficient Scale · ROIC: 7.3% · 5Y Avg: 13.9%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale ★

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ABT shows a Weak competitive edge (54.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 7.3% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$119

Low

$121

Avg Target

$125

High

Based on 5 analysts since Oct 21, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 34Hold: 9Sell: 0Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$122.90

Analysts10

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-10-23	UBS	—	$125	$120	-5	+16.4%	$103.08
2026-10-23	Wells Fargo	—	$119	$120	+1	+17.1%	$102.51
2026-10-22	BTIG	Marie Thibault	$134	$125	-9	+24.3%	$100.57
2026-10-22	Wells Fargo	—	$122	$119	-3	+18.3%	$100.57
2026-10-22	Robert W. Baird	—	$121	$123	+2	+22.3%	$100.57
2026-10-16	New Street	—	$145	$120	-25	+14.7%	$104.60
2026-10-06	Barclays	—	$143	$120	-23	+22.2%	$98.17
2026-10-02	Redburn Partners	Ed Ridley-Day	Initiated	$127	—	+31.3%	$96.71
2026-08-13	Wolfe Research	—	Initiated	$130	—	+17.2%	$110.92
2026-07-28	UBS	Patrick Wood	$115	$125	+10	+14.9%	$108.83
2026-07-20	Benchmark Co.	—	Initiated	$120	—	+19.2%	$100.67
2026-07-17	Piper Sandler	—	$115	$118	+3	+19.4%	$98.82
2026-07-16	BTIG	—	$145	$134	-11	+35.6%	$98.82
2026-07-06	Evercore ISI	Vijay Kumar	$138	$112	-26	+19.6%	$93.64
2026-06-30	Robert W. Baird	David Rescott	Initiated	$121	—	+33.4%	$90.68
2026-04-21	Daiwa	—	Initiated	$92	—	-0.8%	$92.75
2026-04-20	Barclays	Matt Miksic	$142	$143	+1	+47.7%	$96.83
2026-04-17	UBS	—	$158	$115	-43	+20.5%	$95.46
2026-04-17	Piper Sandler	—	$135	$115	-20	+20.5%	$95.46
2026-04-17	Stifel Nicolaus	—	$126	$120	-6	+25.7%	$95.46
2026-03-13	UBS	Danielle Antalffy	$132	$158	+26	+45.7%	$108.42
2026-03-13	New Street	—	$117	$145	+28	+34.1%	$108.14
2026-02-02	Barclays	—	$169	$142	-27	+29.9%	$109.30
2026-01-29	Loop Capital Markets	Ilya Zubkov	Initiated	$120	—	+13.1%	$106.09
2026-01-23	Evercore ISI	—	$144	$138	-6	+27.1%	$108.61
2026-01-23	UBS	—	$128	$132	+4	+21.5%	$108.60
2026-01-23	Mizuho Securities	Anthony Petrone	Initiated	$125	—	+15.1%	$108.60
2026-01-23	Piper Sandler	—	$133	$135	+2	+24.3%	$108.60
2026-01-23	Bernstein	—	$154	$125	-29	+15.1%	$108.60
2026-01-23	Wells Fargo	Larry Biegelsen	$146	$122	-24	+12.3%	$108.60
2026-01-09	Bernstein	Lee Hambright	$135	$154	+19	+22.0%	$126.18
2026-01-09	Goldman Sachs	—	$157	$152	-5	+20.5%	$126.18
2026-01-05	Evercore ISI	—	$128	$144	+16	+16.2%	$123.97
2026-01-05	Barclays	—	$162	$169	+7	+36.1%	$124.19
2025-12-22	BTIG	Marie Thibault	$139	$145	+6	+14.9%	$126.24
2025-11-21	Tigress Financial	—	Initiated	$145	—	+13.2%	$128.12
2025-10-17	Barclays	—	$140	$162	+22	+26.9%	$127.63
2025-10-16	Wells Fargo	—	$150	$146	-4	+12.8%	$129.45
2025-10-01	Goldman Sachs	—	$121	$157	+36	+17.2%	$133.94
2025-07-15	RBC Capital	Shagun Singh	$140	$147	+7	+11.8%	$131.49
2025-04-15	RBC Capital	Shagun Singh	$130	$140	+10	+10.9%	$126.22
2025-01-08	Bernstein	Lee Hambright	$138	$135	-3	+18.2%	$114.25
2024-10-17	Piper Sandler	Adam Maeder	$131	$133	+2	+12.9%	$117.82
2024-10-17	Bernstein	Lee Hambright	$133	$138	+5	+17.1%	$117.82
2024-10-16	Jefferies	Matthew Taylor	$120	$125	+5	+6.1%	$117.82
2024-10-16	Evercore ISI	Vijay Kumar	$120	$128	+8	+8.6%	$117.82
2024-10-16	BTIG	Marie Thibault	$135	$139	+4	+18.0%	$117.82
2024-10-08	Oppenheimer	Suraj Kalia	Initiated	$130	—	+13.7%	$114.30
2024-10-08	RBC Capital	Shagun Singh	$345	$130	-215	+14.7%	$113.36
2024-09-19	RBC Capital	Jonathan Atkin	$125	$345	+220	+533.1%	$54.49

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-

Oct 27, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ABT receives an overall rating of C-. Strongest factors: DCF (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

Rating Change History

Date	From	To
2026-10-23	B	C-
2026-08-14	B+	B
2026-08-04	B	B+
2026-08-03	B+	B
2026-07-29	C	B+
2026-07-22	B	C
2026-07-16	B+	B
2026-07-15	B	B+
2026-07-01	B+	B
2026-05-14	B	B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 57 Grade A

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ABT scores highest in Safety (80/100) and lowest in Growth (28/100). An overall grade of A places ABT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

3.02

Safe Zone

Piotroski F-Score

5/9

✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓ ✗

Beneish M-Score

-2.69

Unlikely Manipulator

Ohlson O-Score

-8.73

Bankruptcy prob: 0.0%

Low Risk

Credit Rating

A+

Score: 75.7/100

Trend: Deteriorating

Earnings Quality

100/100

OCF/NI: 1.83x

Accruals: -4.6%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ABT scores 3.02, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ABT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ABT's score of -2.69 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ABT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ABT receives an estimated rating of A+ (score: 75.7/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ABT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

38.19x

PEG

-0.57x

P/S

3.70x

P/B

3.51x

P/FCF

18.01x

P/OCF

15.86x

EV/EBITDA

16.80x

EV/Revenue

3.95x

EV/EBIT

23.01x

EV/FCF

21.11x

Earnings Yield

3.45%

FCF Yield

5.55%

Shareholder Yield

3.88%

Graham Number

$45.32

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 38.2x earnings, ABT commands a growth premium. Graham's intrinsic value formula yields $45.32 per share, 128% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.722

NI / EBT

Interest Burden

0.939

EBT / EBIT

EBIT Margin

0.172

EBIT / Rev

Asset Turnover

0.482

Rev / Assets

Equity Multiplier

1.900

Assets / Equity

ROE

10.7%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ABT's ROE of 10.7% is driven by Asset Turnover (0.482), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate

1.82%

Fair P/E

12.14x

Intrinsic Value

$37.77

Price/Value

2.39x

Margin of Safety

-138.55%

Premium

138.55%

Assessment

Neutral

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ABT's realized 1.8% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. ABT trades at a 139% premium to its adjusted intrinsic value of $37.77, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 12.1x compares to the current market P/E of 38.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$103.13

Median 1Y

$104.32

5th Pctile

$69.20

95th Pctile

$157.58

Ann. Volatility

25.6%

Analyst Target

$122.90

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Robert B. Ford , Chairman of the Board and Chief Executive Officer	$1,500,000	$8,787,378	$24,198,660
Philip P. Boudreau , Executive Vice President, Finance and Chief Financial Officer	$974,231	$3,045,935	$9,090,636
Lisa D. Earnhardt , Executive Vice President and Group President, Medical Devices	$924,231	$2,543,989	$8,069,724
Hubert L. Allen , Former Executive Vice President, General Counsel and Secretary	$524,019	$2,095,392	$6,995,583
Christopher J. Scoggins , Executive Vice President, Diabetes Care	$859,502	$1,662,503	$6,601,667
Daniel G. Salvadori , Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products	$924,231	$2,238,786	$6,534,285

CEO Pay Ratio

225:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $24,198,660

Avg Employee Cost (SGA/emp): $107,635

Employees: 115,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

115,000

+0.9% YoY

Revenue / Employee

$385,461

Rev: $44,328,000,000

Profit / Employee

$56,730

NI: $6,524,000,000

SGA / Employee

$107,635

Avg labor cost proxy

R&D / Employee

$25,696

Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
ROE	22.0%	20.6%	22.4%	24.3%	22.5%	19.1%	16.0%	14.0%	14.1%	15.2%	14.9%	14.5%	14.9%	31.1%	30.8%	31.1%	30.8%	13.1%	12.4%	10.7%	10.67%
ROA	10.1%	9.6%	10.5%	11.6%	10.8%	9.3%	7.9%	7.0%	7.1%	7.8%	7.7%	7.6%	7.9%	17.3%	17.5%	17.8%	17.6%	7.8%	6.5%	5.6%	5.62%
ROIC	18.6%	17.7%	19.2%	19.9%	18.8%	15.7%	12.9%	10.9%	10.9%	11.7%	11.9%	12.1%	12.2%	23.9%	23.9%	23.6%	23.8%	10.6%	8.0%	7.3%	7.33%
ROCE	14.3%	13.9%	15.3%	16.7%	16.1%	14.6%	12.6%	11.5%	11.5%	12.4%	12.3%	12.1%	12.6%	11.3%	11.7%	12.0%	12.5%	12.7%	9.2%	8.8%	8.75%
Gross Margin	55.5%	54.1%	53.5%	51.3%	50.0%	49.3%	49.3%	49.6%	49.6%	51.3%	50.4%	51.1%	51.0%	51.0%	52.6%	56.4%	55.7%	57.0%	56.3%	58.0%	58.00%
Operating Margin	24.0%	21.3%	24.3%	20.7%	16.4%	14.3%	14.4%	15.1%	16.5%	18.2%	13.9%	16.2%	17.1%	18.1%	16.3%	18.4%	18.1%	19.6%	16.5%	14.2%	14.15%
Net Margin	19.2%	17.3%	20.6%	17.9%	13.8%	10.2%	13.5%	13.8%	14.2%	15.6%	12.3%	12.5%	15.5%	84.1%	12.8%	16.0%	14.5%	15.5%	9.6%	7.4%	7.37%
EBITDA Margin	31.7%	28.8%	31.2%	29.0%	25.3%	22.7%	26.0%	25.9%	26.1%	27.8%	23.7%	24.9%	27.3%	27.2%	25.8%	27.4%	27.2%	24.6%	20.1%	22.2%	22.19%
FCF Margin	22.0%	20.1%	18.3%	18.6%	19.0%	17.9%	16.4%	13.6%	11.2%	12.6%	12.2%	13.9%	15.7%	15.1%	15.7%	15.7%	15.8%	16.7%	16.3%	18.7%	18.72%
OCF Margin	26.6%	24.5%	22.4%	22.5%	22.9%	21.9%	20.9%	18.5%	16.4%	18.1%	17.7%	19.4%	21.2%	20.4%	21.1%	21.0%	20.8%	21.6%	21.0%	21.3%	21.26%
ROE 3Y Avg	snapshot only																				17.46%
ROE 5Y Avg	snapshot only																				17.94%
ROA 3Y Avg	snapshot only																				9.74%
ROIC 3Y Avg	snapshot only																				10.77%
ROIC Economic	snapshot only																				6.92%
Cash ROA	snapshot only																				9.07%
Cash ROIC	snapshot only																				12.68%
CROIC	snapshot only																				11.16%
NOPAT Margin	snapshot only																				12.30%
Pretax Margin	snapshot only																				16.12%
R&D / Revenue	snapshot only																				6.78%
SGA / Revenue	snapshot only																				28.93%
SBC / Revenue	snapshot only																				1.54%

Valuation

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
P/E Ratio	26.96	32.90	25.32	20.95	20.31	26.20	28.96	35.21	31.39	32.35	34.16	31.81	33.75	14.46	16.94	16.88	16.69	33.55	28.40	28.95	38.185
P/S Ratio	4.62	5.40	4.39	3.94	3.56	4.16	4.05	4.52	4.05	4.62	4.77	4.34	4.72	4.62	5.40	5.48	5.32	4.94	3.95	3.37	3.699
P/B Ratio	5.67	6.50	5.53	4.91	4.49	4.95	4.54	4.89	4.32	4.80	4.96	4.50	4.89	4.07	4.68	4.67	4.58	4.20	3.42	3.07	3.506
P/FCF	20.97	26.90	23.99	21.17	18.76	23.28	24.63	33.11	36.07	36.59	39.06	31.27	30.01	30.52	34.35	34.84	33.72	29.60	24.16	18.01	18.010
P/OCF	17.34	22.09	19.64	17.50	15.52	18.96	19.41	24.38	24.74	25.49	26.92	22.38	22.30	22.65	25.55	26.12	25.58	22.88	18.83	15.86	15.855
EV/EBITDA	16.68	19.87	15.95	13.60	12.93	15.93	16.38	18.97	16.96	18.27	19.19	17.68	18.89	18.56	21.09	20.86	20.21	19.35	18.29	16.80	16.799
EV/Revenue	4.82	5.61	4.59	4.10	3.70	4.34	4.23	4.73	4.27	4.83	4.97	4.53	4.90	4.79	5.55	5.62	5.44	5.08	4.54	3.95	3.951
EV/EBIT	23.43	28.03	21.76	18.04	17.46	21.97	23.52	27.96	25.01	26.31	27.85	25.68	27.04	26.41	29.47	28.59	27.51	25.33	24.15	23.01	23.006
EV/FCF	21.90	27.94	25.09	22.05	19.52	24.27	25.71	34.69	37.96	38.29	40.67	32.60	31.12	31.67	35.31	35.75	34.47	30.43	27.79	21.11	21.107
Earnings Yield	3.7%	3.0%	3.9%	4.8%	4.9%	3.8%	3.5%	2.8%	3.2%	3.1%	2.9%	3.1%	3.0%	6.9%	5.9%	5.9%	6.0%	3.0%	3.5%	3.5%	3.45%
FCF Yield	4.8%	3.7%	4.2%	4.7%	5.3%	4.3%	4.1%	3.0%	2.8%	2.7%	2.6%	3.2%	3.3%	3.3%	2.9%	2.9%	3.0%	3.4%	4.1%	5.6%	5.55%
EV/OCF	snapshot only																				18.581
EV/Gross Profit	snapshot only																				6.955
Acquirers Multiple	snapshot only																				23.203
Shareholder Yield	snapshot only																				3.88%
Graham Number	snapshot only																				$45.32

Leverage & Solvency

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Current Ratio	1.83	1.85	1.85	2.01	1.86	1.63	1.68	1.64	1.74	1.64	1.60	1.68	1.60	1.67	1.78	1.82	1.70	1.58	1.39	1.38	1.376
Quick Ratio	1.42	1.46	1.40	1.54	1.43	1.23	1.22	1.16	1.23	1.16	1.11	1.18	1.14	1.23	1.27	1.30	1.24	1.18	1.01	0.97	0.966
Debt/Equity	0.53	0.54	0.48	0.46	0.46	0.49	0.46	0.45	0.41	0.41	0.38	0.38	0.38	0.32	0.27	0.27	0.25	0.29	0.65	0.64	0.638
Net Debt/Equity	0.25	0.25	0.25	0.20	0.18	0.21	0.20	0.23	0.23	0.22	0.20	0.19	0.18	0.15	0.13	0.12	0.10	0.12	0.51	0.53	0.528
Debt/Assets	0.25	0.26	0.23	0.23	0.23	0.24	0.23	0.23	0.22	0.22	0.20	0.20	0.20	0.19	0.16	0.16	0.15	0.17	0.31	0.30	0.299
Debt/EBITDA	1.50	1.58	1.33	1.22	1.27	1.51	1.58	1.68	1.54	1.50	1.40	1.42	1.40	1.41	1.19	1.16	1.10	1.30	3.04	2.98	2.976
Net Debt/EBITDA	0.71	0.74	0.70	0.54	0.50	0.65	0.69	0.87	0.84	0.81	0.76	0.72	0.67	0.67	0.57	0.53	0.44	0.53	2.39	2.46	2.465
Interest Coverage	20.02	21.03	26.55	34.16	39.80	27.37	15.97	12.73	10.87	10.55	11.01	10.74	10.88	12.63	12.86	14.78	19.22	21.20	18.49	12.56	12.559
Equity Multiplier	2.14	2.10	2.09	2.03	2.04	2.03	1.99	1.97	1.92	1.90	1.87	1.86	1.87	1.71	1.67	1.66	1.65	1.66	2.12	2.14	2.137
Cash Ratio	snapshot only																				0.315
Debt Service Coverage	snapshot only																				17.199
Cash to Debt	snapshot only																				0.172
FCF to Debt	snapshot only																				0.267
Defensive Interval	snapshot only																				279.3 days

Efficiency & Turnover

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Asset Turnover	0.59	0.58	0.61	0.62	0.61	0.58	0.56	0.55	0.55	0.54	0.55	0.56	0.56	0.54	0.55	0.55	0.55	0.53	0.47	0.48	0.482
Inventory Turnover	3.77	3.91	3.70	3.73	3.91	3.77	3.36	3.18	3.26	3.15	2.97	2.94	3.00	3.23	3.06	2.96	2.98	3.11	2.89	2.82	2.821
Receivables Turnover	7.02	6.68	6.71	6.84	7.03	6.87	6.29	6.02	6.19	6.28	6.39	6.25	6.08	6.22	6.08	5.82	5.77	5.97	5.81	5.62	5.622
Payables Turnover	5.44	4.75	4.65	4.97	5.27	4.73	4.65	4.66	4.99	4.51	4.81	4.82	5.05	4.85	4.90	4.83	4.95	4.68	4.43	4.42	4.423
DSO	52	55	54	53	52	53	58	61	59	58	57	58	60	59	60	63	63	61	63	65	64.9 days
DIO	97	93	99	98	93	97	109	115	112	116	123	124	122	113	119	123	122	117	126	129	129.4 days
DPO	67	77	79	73	69	77	79	78	73	81	76	76	72	75	74	76	74	78	82	83	82.5 days
Cash Conversion Cycle	82	71	74	78	76	73	88	97	98	93	104	107	109	97	105	111	112	100	107	112	111.8 days
Fixed Asset Turnover	snapshot only																				3.636
Operating Cycle	snapshot only																				194.3 days
Cash Velocity	snapshot only																				8.314
Capital Intensity	snapshot only																				2.344

Growth (YoY)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue	31.3%	24.5%	19.2%	13.2%	6.4%	1.3%	-6.8%	-11.7%	-11.3%	-8.1%	-2.8%	1.2%	3.1%	4.6%	5.0%	5.9%	6.4%	5.7%	6.6%	8.1%	8.06%
Net Income	1.1%	57.3%	35.0%	34.2%	8.9%	-2.0%	-24.9%	-39.7%	-34.6%	-17.5%	-3.0%	7.7%	11.7%	1.3%	1.4%	1.5%	1.4%	-51.3%	-53.5%	-61.2%	-61.19%
EPS	1.1%	57.9%	36.3%	36.3%	10.4%	-0.4%	-23.9%	-39.2%	-34.0%	-17.2%	-2.9%	7.6%	11.7%	1.3%	1.4%	1.5%	1.4%	-51.3%	-53.5%	-61.0%	-61.01%
FCF	1.0%	51.1%	7.1%	-2.0%	-8.3%	-9.8%	-16.3%	-35.2%	-47.4%	-35.2%	-27.8%	3.0%	44.4%	25.5%	35.2%	19.8%	6.6%	16.4%	10.8%	28.7%	28.71%
EBITDA	57.4%	35.1%	24.8%	23.4%	5.5%	-2.2%	-16.5%	-26.9%	-22.0%	-10.8%	-2.6%	3.8%	6.3%	2.2%	6.8%	11.4%	10.4%	7.3%	0.6%	-5.6%	-5.65%
Op. Income	1.1%	73.9%	49.8%	28.6%	2.2%	-9.1%	-30.9%	-41.1%	-35.6%	-22.8%	-6.4%	9.2%	12.0%	6.6%	11.6%	14.1%	15.3%	17.0%	14.2%	5.1%	5.09%
OCF Growth	snapshot only																				9.60%
Asset Growth	snapshot only																				30.02%
Equity Growth	snapshot only																				1.08%
Debt Growth	snapshot only																				1.43%
Shares Change	snapshot only																				-0.46%
Dividend Growth	snapshot only																				7.74%

Growth (CAGR)

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue 3Y	11.6%	12.1%	13.2%	13.8%	12.8%	11.0%	8.9%	8.6%	7.4%	5.0%	2.6%	0.4%	-0.9%	-0.9%	-1.7%	-1.8%	-0.9%	0.5%	2.8%	5.0%	5.01%
Revenue 5Y	15.4%	15.6%	14.8%	14.0%	12.4%	9.8%	7.8%	6.3%	5.6%	5.6%	5.6%	5.7%	5.6%	5.6%	5.7%	6.5%	6.4%	5.1%	3.9%	3.0%	2.98%
EPS 3Y	1.0%	43.8%	43.4%	43.9%	34.3%	24.1%	18.1%	19.2%	16.0%	9.2%	0.2%	-3.7%	-6.6%	24.6%	21.1%	18.1%	21.3%	-1.9%	2.7%	1.8%	1.82%
EPS 5Y	34.3%	33.3%	38.1%	48.6%	30.1%	70.6%	65.2%	41.3%	42.6%	19.7%	16.9%	14.3%	12.3%	30.0%	30.9%	35.6%	33.4%	8.2%	2.4%	-2.6%	-2.63%
Net Income 3Y	1.0%	44.0%	43.4%	43.5%	33.8%	23.4%	17.5%	18.4%	15.1%	8.4%	-0.6%	-4.5%	-7.3%	23.8%	20.5%	17.8%	21.0%	-2.0%	2.6%	1.7%	1.68%
Net Income 5Y	39.5%	38.3%	38.7%	48.8%	30.3%	70.8%	64.9%	41.0%	42.3%	19.3%	16.5%	13.9%	11.9%	29.4%	30.4%	35.1%	32.8%	7.7%	1.9%	-3.2%	-3.18%
EBITDA 3Y	23.3%	20.9%	21.9%	22.9%	18.5%	14.6%	9.9%	10.3%	9.0%	5.6%	0.5%	-2.1%	-4.4%	-3.8%	-4.6%	-5.4%	-2.9%	-0.7%	1.5%	3.0%	2.96%
EBITDA 5Y	32.1%	33.0%	24.8%	26.5%	18.1%	14.3%	13.0%	9.3%	9.0%	9.0%	8.1%	7.1%	6.6%	6.5%	6.6%	9.2%	8.7%	5.3%	1.7%	-0.3%	-0.30%
Gross Profit 3Y	13.5%	13.6%	14.6%	14.7%	12.9%	10.2%	7.6%	7.7%	7.1%	4.9%	2.0%	-0.6%	-2.5%	-2.8%	-3.2%	-2.3%	0.2%	3.3%	7.0%	9.9%	9.91%
Gross Profit 5Y	14.3%	14.9%	15.6%	16.0%	14.0%	11.3%	8.0%	5.8%	4.9%	4.8%	4.9%	5.0%	5.1%	5.1%	5.5%	7.4%	8.0%	7.2%	5.9%	4.8%	4.77%
Op. Income 3Y	39.1%	33.8%	36.3%	35.1%	29.4%	22.4%	14.5%	14.6%	12.1%	6.8%	-1.0%	-6.2%	-9.7%	-9.2%	-10.3%	-9.8%	-6.0%	-1.3%	6.0%	9.4%	9.42%
Op. Income 5Y	24.4%	23.3%	30.4%	36.0%	33.6%	33.6%	20.6%	13.2%	12.1%	10.9%	10.4%	9.6%	9.3%	8.6%	9.4%	13.4%	12.7%	8.8%	4.3%	-0.2%	-0.17%
FCF 3Y	23.8%	20.8%	22.4%	27.4%	30.8%	20.2%	15.1%	6.3%	-0.7%	-4.0%	-13.5%	-13.2%	-11.4%	-9.8%	-6.5%	-7.2%	-6.8%	-1.8%	2.6%	16.7%	16.69%
FCF 5Y	38.8%	32.9%	24.5%	21.8%	16.4%	12.0%	6.6%	2.6%	-1.7%	0.6%	2.0%	6.7%	11.2%	7.1%	8.3%	8.2%	8.6%	5.3%	-0.6%	0.2%	0.18%
OCF 3Y	22.2%	18.7%	19.0%	21.4%	23.5%	16.0%	12.1%	5.2%	0.2%	-2.8%	-10.1%	-9.4%	-8.2%	-6.7%	-3.5%	-4.1%	-4.0%	-0.1%	3.0%	9.9%	9.95%
OCF 5Y	31.5%	26.9%	20.8%	18.9%	15.1%	11.5%	7.2%	4.4%	1.2%	2.9%	3.9%	6.7%	9.7%	6.9%	7.8%	7.1%	6.9%	3.9%	-0.7%	-1.4%	-1.40%
Assets 3Y	1.0%	3.8%	3.1%	2.7%	2.0%	3.1%	3.4%	2.2%	1.4%	0.3%	-0.1%	-0.1%	0.3%	2.7%	3.2%	4.2%	5.0%	5.2%	14.4%	14.2%	14.19%
Assets 5Y	13.3%	6.5%	0.9%	0.8%	0.2%	-0.5%	0.8%	1.4%	0.1%	1.7%	1.4%	1.3%	1.6%	3.7%	4.1%	4.1%	4.0%	3.6%	8.7%	8.3%	8.31%
Equity 3Y	3.9%	5.5%	4.6%	4.8%	3.9%	5.7%	7.0%	6.7%	6.1%	5.6%	5.0%	5.2%	5.0%	10.0%	11.3%	11.5%	12.6%	12.4%	12.0%	11.2%	11.20%
Book Value 3Y	3.6%	5.3%	4.6%	5.1%	4.3%	6.2%	7.6%	7.4%	6.9%	6.4%	5.8%	6.0%	5.8%	10.8%	11.9%	11.8%	12.9%	12.6%	12.1%	11.3%	11.35%
Dividend 3Y	6.6%	7.6%	6.0%	4.5%	2.9%	1.6%	1.9%	2.4%	2.8%	3.2%	3.3%	3.3%	3.4%	3.3%	3.1%	2.7%	2.7%	2.5%	2.5%	2.5%	2.50%

Growth Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Revenue Stability	0.89	0.95	0.96	0.93	0.92	0.92	0.85	0.71	0.65	0.68	0.61	0.48	0.43	0.47	0.44	0.44	0.51	0.64	0.87	0.69	0.692
Earnings Stability	0.69	0.88	0.89	0.89	0.83	0.96	0.82	0.65	0.62	0.69	0.49	0.30	0.26	0.65	0.54	0.47	0.45	0.23	0.12	0.04	0.035
Margin Stability	0.95	0.96	0.98	0.97	0.96	0.96	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.97	0.96	0.96	0.95	0.95	0.947
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50	0.50	0.50	0.50	1.00	1.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.86	0.86	0.96	0.99	0.90	0.84	0.86	0.93	0.99	0.97	0.95	0.50	0.50	0.50	0.50	0.50	0.50	0.50	0.500
Earnings Smoothness	0.27	0.55	0.70	0.71	0.91	0.98	0.72	0.51	0.58	0.81	0.97	0.93	0.89	0.20	0.18	0.14	0.17	0.31	0.27	0.12	0.118
ROE Trend	0.10	0.07	0.07	0.09	0.06	0.02	-0.04	-0.07	-0.08	-0.04	-0.04	-0.05	-0.03	0.11	0.13	0.14	0.13	-0.09	-0.09	-0.10	-0.103
Gross Margin Trend	0.03	0.03	0.02	0.02	0.01	-0.01	-0.02	-0.03	-0.04	-0.03	-0.02	-0.01	0.00	0.00	0.01	0.03	0.04	0.05	0.06	0.05	0.051
FCF Margin Trend	0.09	0.05	0.01	0.01	0.01	-0.00	-0.03	-0.06	-0.09	-0.06	-0.05	-0.02	0.01	-0.00	0.01	0.02	0.02	0.03	0.02	0.04	0.039
Sustainable Growth Rate	12.8%	11.3%	13.0%	15.1%	13.1%	10.0%	6.7%	4.7%	4.6%	5.8%	5.3%	4.9%	5.2%	22.2%	21.9%	22.3%	21.9%	4.8%	4.1%	2.3%	2.29%
Internal Growth Rate	6.2%	5.5%	6.5%	7.7%	6.7%	5.1%	3.4%	2.4%	2.4%	3.0%	2.8%	2.6%	2.8%	14.1%	14.2%	14.6%	14.3%	2.9%	2.2%	1.2%	1.22%

Cash Flow Quality

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
OCF/Net Income	1.55	1.49	1.29	1.20	1.31	1.38	1.49	1.44	1.27	1.27	1.27	1.42	1.51	0.64	0.66	0.65	0.65	1.47	1.51	1.83	1.826
FCF/OCF	0.83	0.82	0.82	0.83	0.83	0.81	0.79	0.74	0.69	0.70	0.69	0.72	0.74	0.74	0.74	0.75	0.76	0.77	0.78	0.88	0.880
FCF/Net Income	snapshot only																				1.607
OCF/EBITDA	snapshot only																				0.904
CapEx/Revenue	4.6%	4.4%	4.1%	3.9%	4.0%	4.1%	4.4%	4.9%	5.1%	5.5%	5.5%	5.5%	5.4%	5.3%	5.4%	5.2%	5.0%	4.9%	4.6%	2.5%	2.54%
CapEx/Depreciation	snapshot only																				0.401
Accruals Ratio	-0.06	-0.05	-0.03	-0.02	-0.03	-0.04	-0.04	-0.03	-0.02	-0.02	-0.02	-0.03	-0.04	0.06	0.06	0.06	0.06	-0.04	-0.03	-0.05	-0.046
Sloan Accruals	snapshot only																				-0.075
Cash Flow Adequacy	snapshot only																				1.819
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Dividend Yield	1.6%	1.4%	1.7%	1.8%	2.0%	1.8%	2.0%	1.9%	2.2%	1.9%	1.9%	2.1%	1.9%	2.0%	1.7%	1.7%	1.7%	1.9%	2.3%	2.7%	2.44%
Dividend/Share	$1.70	$1.80	$1.82	$1.85	$1.86	$1.89	$1.92	$1.96	$2.00	$2.03	$2.07	$2.11	$2.15	$2.20	$2.23	$2.27	$2.31	$2.36	$2.40	$2.44	$2.52
Payout Ratio	42.0%	45.3%	41.9%	38.1%	41.6%	47.7%	58.0%	66.4%	67.6%	62.1%	64.4%	66.5%	65.3%	28.6%	28.9%	28.4%	28.9%	63.1%	66.7%	78.5%	78.54%
FCF Payout Ratio	32.7%	37.0%	39.7%	38.5%	38.4%	42.4%	49.3%	62.5%	77.7%	70.3%	73.6%	65.3%	58.1%	60.4%	58.7%	58.6%	58.5%	55.7%	56.8%	48.9%	48.86%
Total Payout Ratio	62.5%	77.8%	97.9%	83.3%	93.4%	1.0%	93.0%	1.1%	99.7%	83.6%	80.6%	75.3%	86.8%	38.3%	38.9%	38.1%	35.4%	76.8%	79.4%	1.1%	1.12%
Div. Increase Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Chowder Number	0.24	0.26	0.20	0.15	0.10	0.05	0.06	0.07	0.08	0.09	0.09	0.10	0.10	0.10	0.09	0.09	0.09	0.09	0.10	0.10	0.100
Buyback Yield	0.8%	1.0%	2.2%	2.2%	2.5%	2.1%	1.2%	1.3%	1.0%	0.7%	0.5%	0.3%	0.6%	0.7%	0.6%	0.6%	0.4%	0.4%	0.4%	1.2%	1.17%
Net Buyback Yield	0.8%	1.0%	2.2%	2.2%	2.5%	2.1%	1.2%	1.3%	1.0%	0.7%	0.5%	0.3%	0.6%	0.7%	0.6%	0.6%	0.4%	0.4%	0.3%	1.0%	1.04%
Total Shareholder Return	2.3%	2.4%	3.9%	4.0%	4.6%	3.9%	3.2%	3.2%	3.2%	2.6%	2.4%	2.4%	2.6%	2.6%	2.3%	2.3%	2.1%	2.3%	2.7%	3.8%	3.76%

DuPont Factors

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Tax Burden (NI/EBT)	0.88	0.86	0.85	0.85	0.85	0.83	0.83	0.82	0.83	0.86	0.86	0.85	0.85	1.91	1.84	1.77	1.72	0.77	0.77	0.72	0.722
Interest Burden (EBT/EBIT)	0.95	0.95	0.96	0.97	0.97	0.96	0.94	0.92	0.91	0.91	0.91	0.91	0.91	0.92	0.92	0.93	0.94	0.95	0.96	0.94	0.939
EBIT Margin	0.21	0.20	0.21	0.23	0.21	0.20	0.18	0.17	0.17	0.18	0.18	0.18	0.18	0.18	0.19	0.20	0.20	0.20	0.19	0.17	0.172
Asset Turnover	0.59	0.58	0.61	0.62	0.61	0.58	0.56	0.55	0.55	0.54	0.55	0.56	0.56	0.54	0.55	0.55	0.55	0.53	0.47	0.48	0.482
Equity Multiplier	2.17	2.15	2.13	2.10	2.09	2.06	2.04	2.00	1.98	1.96	1.93	1.91	1.90	1.79	1.76	1.75	1.75	1.68	1.90	1.90	1.900

Per Share

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
EPS (Diluted TTM)	$4.05	$3.97	$4.35	$4.85	$4.47	$3.95	$3.31	$2.95	$2.95	$3.27	$3.22	$3.17	$3.30	$7.68	$7.73	$7.98	$7.99	$3.73	$3.59	$3.11	$3.11
Book Value/Share	$19.24	$20.09	$19.94	$20.67	$20.22	$20.92	$21.13	$21.24	$21.44	$22.08	$22.18	$22.45	$22.77	$27.30	$27.94	$28.88	$29.13	$29.84	$29.80	$29.32	$29.78
Tangible Book/Share	$-1.22	$-0.09	$-0.00	$1.22	$1.44	$1.96	$2.33	$2.33	$2.82	$3.49	$4.07	$4.67	$5.03	$10.26	$10.98	$11.82	$12.23	$12.92	$-0.59	$-0.77	$-0.77
Revenue/Share	$23.65	$24.17	$25.08	$25.81	$25.53	$24.89	$23.69	$22.98	$22.86	$22.95	$23.04	$23.26	$23.58	$24.03	$24.24	$24.62	$25.07	$25.37	$25.84	$26.73	$27.75
FCF/Share	$5.21	$4.85	$4.59	$4.80	$4.84	$4.45	$3.90	$3.14	$2.57	$2.89	$2.81	$3.23	$3.71	$3.64	$3.81	$3.87	$3.95	$4.23	$4.22	$5.00	$5.02
OCF/Share	$6.30	$5.91	$5.61	$5.80	$5.85	$5.46	$4.94	$4.26	$3.75	$4.15	$4.08	$4.51	$4.99	$4.90	$5.12	$5.16	$5.21	$5.48	$5.42	$5.68	$5.70
Cash/Share	$5.42	$5.75	$4.60	$5.26	$5.62	$5.80	$5.44	$4.66	$4.03	$4.16	$3.80	$4.12	$4.46	$4.56	$3.92	$4.16	$4.42	$5.12	$4.18	$3.21	$3.22
EBITDA/Share	$6.84	$6.82	$7.23	$7.78	$7.31	$6.78	$6.11	$5.74	$5.75	$6.07	$5.96	$5.95	$6.11	$6.21	$6.38	$6.63	$6.74	$6.66	$6.42	$6.29	$6.29
Debt/Share	$10.28	$10.80	$9.63	$9.50	$9.30	$10.23	$9.65	$9.62	$8.88	$9.08	$8.33	$8.43	$8.57	$8.75	$7.58	$7.67	$7.40	$8.62	$19.49	$18.71	$18.71
Net Debt/Share	$4.87	$5.05	$5.03	$4.23	$3.69	$4.43	$4.21	$4.97	$4.85	$4.92	$4.53	$4.30	$4.11	$4.19	$3.66	$3.52	$2.98	$3.51	$15.31	$15.49	$15.49

Academic Models

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	3.020
Altman Z-Prime	snapshot only																				5.251
Piotroski F-Score	8	9	9	8	8	6	5	4	5	7	6	8	8	6	7	7	6	6	5	5	5
Beneish M-Score	-2.68	-2.72	-2.45	-2.42	-2.60	-2.65	-2.81	-2.76	-2.55	-2.53	-2.51	-2.56	-2.61	-2.09	-2.08	-1.76	-2.06	-2.57	-2.40	-2.69	-2.694
Ohlson O-Score	snapshot only																				-8.729
Net-Net WC	snapshot only																				$-18.90
EVA	snapshot only																				$-2082422646.78

Credit

Metric	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Q2'26	Current
Credit Rating	snapshot only																				A+
Credit Score	92.73	89.00	88.86	93.48	93.62	90.84	87.98	87.48	86.30	87.46	86.98	87.36	87.00	87.20	90.38	90.58	91.60	90.24	76.36	75.67	75.667
Credit Grade	snapshot only																				5
Credit Trend	snapshot only																				-14.916
Implied Spread (bps)	snapshot only																				125.000
Industry Credit Rank	snapshot only																				74
Sector Credit Rank	snapshot only																				73

ABT NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet